SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-276121
Filing Date
2021-09-17
Accepted
2021-09-17 16:01:55
Documents
14
Period of Report
2021-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d224855d8k.htm   iXBRL 8-K 30647
2 EX-99.1 d224855dex991.htm EX-99.1 21017
6 GRAPHIC g224855g39k65.jpg GRAPHIC 3265
  Complete submission text file 0001193125-21-276121.txt   184017

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20210917.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20210917_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20210917_pre.xml EX-101.PRE 10954
7 EXTRACTED XBRL INSTANCE DOCUMENT d224855d8k_htm.xml XML 3227
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 211260367
SIC: 2834 Pharmaceutical Preparations